Tripathy Devjit, Almgren Peter, Tuomi Tiinamaija, Groop Leif
Department of Endocrinology, University Hospital MAS, Lund University, Malmö, S-20502 Sweden.
Diabetes Care. 2004 Sep;27(9):2204-10. doi: 10.2337/diacare.27.9.2204.
The goal of this study was to evaluate the performance of surrogate measures of insulin sensitivity and insulin secretion.
The homeostasis model assessment (HOMA) of insulin resistance (IR) and the insulin sensitivity index (S(i)) from oral glucose tolerance test (OGTT) were compared with the M value from a hyperinsulinemic-euglycemic clamp in 467 subjects with various degrees of glucose tolerance. Endogenous glucose production (EGP) and hepatic insulin sensitivity were determined in a subset (n = 143). Insulin secretion was estimated as the HOMA beta-cell index and as the insulinogenic index from the first 30 min of the OGTT (I/G30) and compared with the first-phase insulin response (FPIR) to an intravenous glucose tolerance test (n = 218).
The M value correlated with the HOMA-IR (r = -0.591, P < 0.0001) and the S(i) (r = 0.533, P < 0.0001) indexes in the total study group. HOMA-IR correlated with basal EGP in the total study group (r = 0.378, P < 0.0005) and in subjects with diabetes (r = 0.330, P = 0.01). However, neither HOMA-IR nor S(i) correlated significantly with the M value in subjects with impaired fasting glucose (IFG) (r = -0.108, P = 0.5; r = 0.01, P = 0.9) or IFG/impaired glucose tolerance (IGT) (r = -0.167, P = 0.4; r = 0.09, P = 0.6). The HOMA-IR correlated with hepatic insulin sensitivity in the whole study group (r = -0.395, P < 0.005) as well as in the IFG/IGT subgroup (r = -0.634, P = 0.002) and in the diabetic subgroup (r = -0.348, P = 0.008). In subjects with IFG/IGT, hepatic insulin sensitivity was the most important determinant of HOMA-IR, explaining 40% of its variation. The HOMA beta-cell index showed a weak correlation with FPIR in the whole study group (r = 0.294, P = 0.001) but not in the subgroups. In contrast, the I/G30 correlated with FPIR in the whole study group (r = 0.472, P < 0.0005) and in the IFG/IGT subgroup (r = 0.493, P < 0.005).
HOMA-IR is dependent upon both peripheral and hepatic insulin sensitivity, the contribution of which differs between subjects with normal and elevated fasting glucose concentrations. These discrepancies develop as a consequence of a nonparallel deterioration of the variables included in the equations with worsening of glucose tolerance.
本研究旨在评估胰岛素敏感性和胰岛素分泌替代指标的性能。
将467例不同糖耐量程度的受试者的胰岛素抵抗(IR)的稳态模型评估(HOMA)和口服葡萄糖耐量试验(OGTT)中的胰岛素敏感性指数(S(i))与高胰岛素正葡萄糖钳夹试验中的M值进行比较。在一个亚组(n = 143)中测定内源性葡萄糖生成(EGP)和肝脏胰岛素敏感性。胰岛素分泌通过HOMA β细胞指数以及OGTT最初30分钟的胰岛素生成指数(I/G30)进行估算,并与静脉葡萄糖耐量试验的第一相胰岛素反应(FPIR)进行比较(n = 218)。
在整个研究组中,M值与HOMA-IR(r = -0.591,P < 0.0001)和S(i)(r = 0.533,P < 0.0001)指数相关。在整个研究组中,HOMA-IR与基础EGP相关(r = 0.378,P < 0.0005),在糖尿病患者中也相关(r = 0.330,P = 0.01)。然而,在空腹血糖受损(IFG)患者(r = -0.108,P = 0.5;r = 0.01,P = 0.9)或IFG/糖耐量受损(IGT)患者中,HOMA-IR和S(i)与M值均无显著相关性(r = -0.167,P = 0.4;r = 0.09,P = 0.6)。在整个研究组以及IFG/IGT亚组(r = -0.634,P = 0.002)和糖尿病亚组(r = -0.348,P = 0.008)中,HOMA-IR与肝脏胰岛素敏感性相关。在IFG/IGT患者中,肝脏胰岛素敏感性是HOMA-IR的最重要决定因素,解释了其40%的变异。在整个研究组中,HOMA β细胞指数与FPIR呈弱相关(r = 0.294,P = 0.001),但在亚组中无相关性。相比之下,在整个研究组以及IFG/IGT亚组中,I/G30与FPIR相关(r = 0.472,P < 0.0005;r = 0.493,P < 0.005)。
HOMA-IR取决于外周和肝脏胰岛素敏感性,空腹血糖浓度正常和升高的受试者之间其贡献有所不同。这些差异是由于随着糖耐量恶化,方程中包含的变量非平行恶化所致。